The present invention discloses dual release bilayer pharmaceutical formulation in unit dosage form comprising metformin or its acid addition salt. The formulation has an advantage of achieving the minimum effective concentration (MEC) rapidly along with maintaining therapeutic plasma concentration in effective range for several hours, thus controlling blood glucose throughout the length of time.
